Elevated levels of plasma matrix metalloproteinase-9 in patients with atopic dermatitis: a pilot study

被引:28
作者
Devillers, A. C. A.
van Toorenenbergen, A. W.
Heerenbrink, G. J. Klein
Mulder, P. G. H.
Oranje, A. P.
机构
[1] Erasmus MC, Dept Dermatol & Venerol, Rotterdam, Netherlands
[2] Erasmus MC, Dept Clin Chem, Rotterdam, Netherlands
[3] Erasmus MC, Dept Epidemiol & Biostat, Rotterdam, Netherlands
关键词
D O I
10.1111/j.1365-2230.2007.02378.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Matrix metalloproteinase (MMP)-9 has been shown to play a role in the infiltration of inflammatory cells in various tissues. It is thus part of the pathogenesis of many inflammatory diseases, including asthma and allergic rhinitis/conjunctivitis. We compared plasma MMP-9 levels of 20 patients with atopic dermatitis (AD) with that of 17 control subjects. Additional outcome parameters consisted of the modified objective SCORing Atopic Dermatitis and the Three Item Severity score in patients, and peripheral blood leucocytes and eosinophils in both groups. Plasma MMP-9 levels were found to be significantly higher in patients compared with controls, supporting a role for MMP-9 in the pathogenesis of AD.
引用
收藏
页码:311 / 313
页数:3
相关论文
共 10 条
[1]   Gelatinase expression at positive patch test reactions [J].
Giannelli, G ;
Foti, C ;
Marinosci, F ;
Bonamonte, D ;
Antonaci, S ;
Angelini, G .
CONTACT DERMATITIS, 2002, 46 (05) :280-285
[2]   Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: Potential implications in asthma and other lung diseases [J].
Gueders, MM ;
Foidart, JM ;
Noel, A ;
Cataldo, DD .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2006, 533 (1-3) :133-144
[3]   Atopy patch test with house dust mite allergen - an IgE-mediated reaction? [J].
Holm, L ;
Matuseviciene, G ;
Scheynius, A ;
Linder, MT .
ALLERGY, 2004, 59 (08) :874-882
[4]  
Kelly EAB, 2000, AM J RESP CRIT CARE, V162, P1157
[5]   Increased plasma levels of matrix metalloproteinase-9 are associated with the severity of chronic urticaria [J].
Kessel, A ;
Bishara, R ;
Amital, A ;
Bamberger, E ;
Sabo, E ;
Grushko, G ;
Toubi, E .
CLINICAL AND EXPERIMENTAL ALLERGY, 2005, 35 (02) :221-225
[6]   Clinical validation and guidelines for the SCORAD index: Consensus report of the European task force on atopic dermatitis [J].
Kunz, B ;
Oranje, AP ;
Labreze, L ;
Stalder, JF ;
Ring, J ;
Taieb, A .
DERMATOLOGY, 1997, 195 (01) :10-19
[7]   Effects of age, gender, ethnicity, diurnal variation and exercise on circulating levels of matrix metalloproteinases (MMP)-2 and-9, and their inhibitors, tissue inhibitors of matrix metalloproteinases (TIMP)-1 and-2 [J].
Tayebjee, MH ;
Lip, GYH ;
Blann, AD ;
MacFadyen, RJ .
THROMBOSIS RESEARCH, 2005, 115 (03) :205-210
[8]   Allergen-induced matrix metalloproteinase-9 in nasal lavage fluid [J].
van Toorenenbergen, AW ;
van Wijk, RG ;
Vermeulen, AM .
ALLERGY, 1999, 54 (03) :293-294
[9]   THE UK WORKING PARTY DIAGNOSTIC-CRITERIA FOR ATOPIC-DERMATITIS .1. DERIVATION OF A MINIMUM SET OF DISCRIMINATORS FOR ATOPIC-DERMATITIS [J].
WILLIAMS, HC ;
BURNEY, PGJ ;
HAY, RJ ;
ARCHER, CB ;
SHIPLEY, MJ ;
HUNTER, JJA ;
BINGHAM, EA ;
FINLAY, AY ;
PEMBROKE, AC ;
GRAHAMBROWN, RAC ;
ATHERTON, DA ;
LEWISJONES, MS ;
HOLDEN, CA ;
HARPER, JI ;
CHAMPION, RH ;
POYNER, TF ;
LAUNER, J ;
DAVID, TJ .
BRITISH JOURNAL OF DERMATOLOGY, 1994, 131 (03) :383-396
[10]  
Wolkerstorfer A, 1999, ACTA DERM-VENEREOL, V79, P356